GB1076871A - (phenoxy)phenylacetic acids and derivatives thereof - Google Patents

(phenoxy)phenylacetic acids and derivatives thereof

Info

Publication number
GB1076871A
GB1076871A GB910765A GB910765A GB1076871A GB 1076871 A GB1076871 A GB 1076871A GB 910765 A GB910765 A GB 910765A GB 910765 A GB910765 A GB 910765A GB 1076871 A GB1076871 A GB 1076871A
Authority
GB
United Kingdom
Prior art keywords
alkoxy
ester
halogen
hypocholesterolemic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB910765A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US429130A external-priority patent/US3378582A/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB1076871A publication Critical patent/GB1076871A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/90Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention comprises compounds of the general formula <FORM:1076871/C2/1> wherein R is halogen, haloalkyl, C1- 5 alkoxy, C1- 6 alkanoyl, aryl, aralkyl, aralkoxy, carboxy or C1- 5 alkylsulphonyl; R1 is C1- 5 alkyl or alkoxy; and R2 is halogen, alkenyl or C1- 5 alkoxy; and pharmacologically acceptable amides, esters and salts thereof; and the preparation thereof by reacting an appropriately substituted alkali metal phenate with a suitable monosubstituted phenyl-haloacetic ester and hydrolysing the resulting ester and, if desired, converting the resulting acid to a salt, ester or amide thereof. Pharmaceutical preparations having hypocholesterolemic activity, for oral or parenteral administration, comprise one or more compounds of the invention and an inert diluent, optionally with the addition of a known hypocholesterolemic, therapeutic or nutritive agent. The compositions may be in unit dosage forms such as pills, tablets or capsules, or in elixirs or injectable solutions.
GB910765A 1964-03-20 1965-03-03 (phenoxy)phenylacetic acids and derivatives thereof Expired GB1076871A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US35357964A 1964-03-20 1964-03-20
US42910765A 1965-01-29 1965-01-29
US429130A US3378582A (en) 1964-03-20 1965-01-29 (alpha-phenoxy)-and (alpha-phenylthio)-omegaphenyl-alkanoic acids
US43178965A 1965-02-11 1965-02-11

Publications (1)

Publication Number Publication Date
GB1076871A true GB1076871A (en) 1967-07-26

Family

ID=27502861

Family Applications (1)

Application Number Title Priority Date Filing Date
GB910765A Expired GB1076871A (en) 1964-03-20 1965-03-03 (phenoxy)phenylacetic acids and derivatives thereof

Country Status (5)

Country Link
CH (1) CH502294A (en)
DE (1) DE1518011A1 (en)
FR (2) FR1601054A (en)
GB (1) GB1076871A (en)
NL (1) NL140227B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7301246A (en) * 1972-02-14 1973-08-16
DE3125059A1 (en) * 1981-06-26 1983-01-05 Bayer Ag, 5090 Leverkusen DIOXYBENZOLETHER DERIVATIVES, THESE MEDICINAL PRODUCTS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE

Also Published As

Publication number Publication date
NL6503520A (en) 1965-09-21
DE1518011A1 (en) 1969-07-03
CH502294A (en) 1971-01-31
NL140227B (en) 1973-11-15
FR1601054A (en) 1970-08-10
FR4439M (en) 1966-09-19

Similar Documents

Publication Publication Date Title
GB1388358A (en) Taste-improving formulations of oral penicillins
GB1467110A (en) 4-phenyl-5-oxo-heptenoic acids
GB1076871A (en) (phenoxy)phenylacetic acids and derivatives thereof
ES375067A1 (en) 5beta-taurocholenic acids and 5beta-taurocholadienic acids
GB1015787A (en) Tris-(p-methoxyphenyl)ethylene derivatives
GB1252329A (en)
GB1530074A (en) Rho-acetamidophenol derivatives the preparation thereof and the use of such derivatives as therapeutic agents
GB1065296A (en) Phenthiazine derivatives
ES435604A1 (en) Indolylacetylamino acid derivatives, process for their preparation, and pharmaceutical compositions
GB993545A (en) Substituted 1,5-diarylpyrroles
ES8603829A1 (en) Medicines based on piperidine derivatives, piperidine derivatives and process for their preparation.
GB879425A (en) Choleretic, non-cholagogic agents containing alpha-(hydroxy-phenylcyclohexyl) butyric acids
GB971164A (en) Therapeutic compositions comprising ª‡-aminoxy-alkanoic acids and derivatives thereof
IL42201A (en) 2-((1-benzylcyclopentyl)-imino)pyrrolidine
GB971135A (en) Substituted indanes and their preparation
GB1426200A (en) Nahpthyridine derivatives
GB1233072A (en)
GB1264197A (en)
ES361590A1 (en) Esters of alpha-(1-substituted-3-pyrrolidinyl)-alpha-phenyl acetic acid
GB1078850A (en) Substituted 2-imidazolidones
ES350475A1 (en) Benzoic acid esters of 1-phenyl-1-benzyl-2-methyl-3-dimethylamino-propanol
GB1177407A (en) New Benzoic Acid Esters
GB1318643A (en) Syndonimine derivatives the preparation thereof and compositions containing the same
GB1368251A (en) Theophylinylmethylethanoic acid ester
GB1421685A (en) Phenoxyalkanecarboxylic acid derivative the preparation thereof and pharmaceutical compositions containing it